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Abstract Cells usually become ‘committed’ to differentiate long 
before any actual morphological change is apparent. In one 
model commitment is a decision which corresponds to the 
expression of a control gene, while differentiation is the ultimate 
consequence of that decision. We have been studying adipocyte 
commitment and differentiation at the molecular level. Earlier we 
showed that the introduction of a specific DNA sequence into 
‘uncommitted’ cells renders those cells committed to differentiate 
into adipocytes. Here we report temporal regulation of the 
expression of this DNA sequence; furthermore, we show that this 
RNA is in the non-polyA+ fraction of total cellular RNA. These 
data suggest that coordinate regulation of this and other genes is 
important in promoting differentiation. 
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1. Introduction 
The molecular mechanisms by which a single cell gives rise 
to an entire organism with its multitude of cell types, tissues, 
and organs remain largely unknown. Expression of specific 
genes during differentiation is under spatial and temporal con- 
trols. When a cell is to become a specific cell type, it must 
become determined or committed to a particular differentia- 
tion pathway [ 1,2]. In many cases commitment has been pro- 
posed to begin with the activation, or possibly the creation by 
DNA rearrangement, of one or a small number of genes, 
whose gene-product(s) commit a cell and its descendants to 
carry out a specific differentiation upon induction. Genes re- 
sponsible for early differentiative decisions have been isolated 
in Drosophila and vertebrates [337]. Often, these initiating 
genes encode protein domains that are highly conserved in 
nature. For example, the ‘home0 domain found in genes 
whose products are necessary for proper segmentation of in- 
sects, is found in a range of organisms from fly to human 
[4,8,9]. Some of the most extensively characterized determin- 
ing genes at the molecular level are those for muscle cell 
determination and differentiation [ IO,1 11. In vertebrate em- 
bryos, control by the MyoD family of muscle-specific basic- 
helix-loop-helix proteins, which includes MyoD, myogenin, 
myf5, and MRF4, is critical to skeletal muscle formation 
[ll-161. The MyoD protein seems to activate myogenesis by 
directly binding to the control regions of muscle-specific genes 
[17-191. Thus, myoD is considered to be a ‘master regulatory 
gene’. In contrast to homeotic genes studied in Drosophila or 
C. eleguns, myoD seems to affect the identity of a single cell 
type, not that of many types of cells in pattern formation. 
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We are using adipocyte differentiation as our model system 
to study ‘determination’ or ‘commitment’ genes. We have 
been characterizing a group of genes from mouse and human 
cells that determine adipocyte commitment (AC). Our system 
depends on a cell-culture bioassay of gene activity. The first 
studies were based on the Swiss 3T3 cells [20,21]. When their 
growth is arrested in culture, certain subclones of 3T3 mouse 
fibroblasts such as 3T3-F442A or 3T3-Ll will express the 
adipocyte phenotype at nearly 100% efficiency under appro- 
priate conditions [20-231. Clonal null sublines of 3T3, such as 
3T3C2, which have a very low frequency of spontaneous fat 
conversion were isolated [20-241. We had shown earlier that 
cotransfection of a selective marker (neomycin) with high mo- 
lecular weight DNA isolated from uninduced mouse preadi- 
pocyte fibroblast cells (3T3-F442A) or human fat tissue into 
3T3-C2 recipient cells empowers a significant number of cells 
surviving the drug selection to display the adipocyte pheno- 
type. DNA from 3T3C2 did not convert 3T3-C2 recipients 
into adipocytes upon transfection [24]. Through genomic 
DNA cosmid cloning and subsequent plasmid subcloning, 
we isolated two short DNA sequences (clones A and B). 
Each one alone is capable of committing a variety of mouse 
and rat cells to differentiate into adipocytes [25]. Despite the 
small size of clone A (1.2 kb), it acts functionally as a gene in 
our bioassay. The vector (pUC8) used for subcloning from the 
cosmid library does not provide eukaryotic enhancers, promo- 
ters, splice or polyadenylation signals. Both strands of clone A 
have been sequenced, and fail to show an assembly of splice 
sites, enhancer, promoter, CAAT, TATA, polyadenylation, 
and other recognition sequences consistent with a protein en- 
coding region. A scan of all possible frames did not reveal a 
preferred open reading frame. The longest open reading frame 
of the genomic clone A is 60 amino acids. Since clone A is a 
genomic clone, the possibility remains that through splicing a 
functional protein may emerge. In this communication we 
report the detection of clone A specific RNA at 1 day before 
cells reach confluence; at such time there are no detectable 
cellular or morphological changes. 
2. Materials and methods 
2.1. Cell culture and DNA transfection 
All cells were maintained in DME medium plus 10% calf serum 
(Gibco BRL). Recombinant plasmid DNAs were prepared as de- 
scribed [27]. DNAs were transfected into recipient cells together 
with pKoNeo as a selectable marker. DNA transfections were per- 
formed by the calcium phosphate method modified as previously de- 
scribed [24,25]. 60 mm plates were seeded with recipient cells at a 
density of 4~ 105. 10-20 pg of DNA were transfected or co-trans- 
fected with pKoNeo. Cells taking in exogenous DNA were selected in 
medium containing G418 (Gibco) at the lowest concentration that 
kills untransfected cells in a 2-week period as experimentally deter- 
mined (400 j&ml for C57L-MSF, mouse precrisis skin fibroblast 
cells). Individual G418’ colonies were isolated, expanded, and frozen 
for future analysis. 
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2.2. Adipose conversion 
All G418’ colonies were tested for conversion to adipocytes. After 
approx. 7 days of growth to confluence, 5 @g/ml of insulin are added. 
Visible adipocyte foci can be seen against a background of undiffer- 
entiated cells after = 7714 days. 3 weeks after the first adipocytes are 
seen under phase contrast, plates were fixed with formaldehyde and 
stained with oil-red-O. Fat foci were scanned under a dissecting mi- 
croscope at X 16 or X40 after staining and counted as positive if 
containing at least 50 fat cells [24,25]. 
2.3. RNA 
Total RNA is prepared by TRI REAGENT (Molecular Research 
Center) according to the manufacturer’s directions. Using these meth- 
ods we have routinely obtained about 100 pg of total RNA/IO cm 
plate of confluent cells. Total RNA was quantified by ethidium bro- 
mide staining of ribosomal RNA bands. Poly A+ RNA is obtained 
using the PolyAtract mRNA isolation system (Promega) or MPG 
direct mRNA purification kit (CPG). Both mRNA isolation systems 
gave the same results. Northern blots were performed as described 
earlier [27], using 2040 pg of total RNA per lane. Human fat cDNA 
library was purchased from Clontech. Screening of the cDNA library 
was carried out as described by the manufacturer. 
3. Results 
3.1. Isolation of cell lines with stable integrated clone A DNA 
Clone A can commit mouse and rat fibroblasts to adipogen- 
esis. The ability of clone A to induce fat conversion in pre- 
crisis mouse cells was tested using C57L-MSF precrisis mouse 
skin fibroblasts [25]. About one-third of the neomycin-resist- 
ant C57L-MSF transfectant clones isolated were positive for 
adipocyte differentiation. Since exogenous DNA was taken up 
by co-transfection, we conclude that approximately one-third 
of the neomycin-resistant clones integrated a functional clone 
A DNA, as judged by the abilities of these clones to differ- 
entiate into adipocytes. The number of fat foci (each focus 
containing more than 50 fat cells) ranged from 50 to > 1 Os per 
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Fig. 1. Northern blot hybridization of clone A DNA to total RNA 
isolated from (A). (Left) MSFA-1 cells at different time points: lane 
1, 2 days prior to confluence; lane 2, 1 day prior to confluence; 
lane 3, at confluence. (Right) The same blot reprobed with actin. 
(B) Independent isolations of total RNA from cells at 1 day prior 
to confluence. Lanes 1,2, MSFA-1 cells; lanes 3,4, MSFA-2 cells. 
Note the positive signal consistently appears as a band just below 
the 2% RNA marker. 
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Fig. 2. Northern blot analysis using clone A DNA probe. MSFA-1 
RNA lanes l-3: total, non-polyA+, polyA+; MSFA-3 RNA lanes 
C-6: total, non-polyA+, polyA+. Clone A specific band was only 
detected in total RNA and non-polyA+ RNA of the adipocyte-con- 
version positive cells, MSFA-1, and not in the adipocyte-conversion 
negative cells, MSFA-3. (B) Same blot reprobed with GAPDH as a 
control to demonstrate integrity of RNA samples. 
60 mm plate (>103 means >90% of the plate). Two of the 
clones that gave >103 clones were used for RNA analysis 
(MSFA-1 and MSFA-2). One of the neomycin-resistant but 
adipocyte-differentiation negative clones was used as a nega- 
tive control for RNA analysis (MSFA-3). The background of 
spontaneous fat-cell conversion exhibited by C57L-MSF cells 
is low (between 1 and 5 per 60 mm plate). 
3.2. Detection of clone A-speciJic RNA 
We screened a commercially available human-fat cDNA 
library for clone A specific RNA by using radiolabeled clone 
A DNA as probe. No positive clone was identified. We next 
reasoned that if any RNA product is transcribed in trans- 
fected preadipocytes, it only may appear briefly, only in the 
committed but not differentiated state, or only in low abun- 
dance. To test these possibilities, MSFA-1 and MSFA-3 
RNAs were collected each day from all stages of growth 
through differentiation. We were able to detect the presence 
of clone A RNA from MSFA-1 cells only at 1 day prior to 
confluence (Fig. lA, lane 2), not in RNA from other time 
points (Fig. lA, lanes 1,3). The presence of clone A specific 
RNA in MSFA-1 cells was confirmed with several different 
RNA preparations (Fig. 1B). No positive clone A signal was 
detected in MSFA-3 RNA. Since we did not want to discri- 
minate between polyA+ and non-polyA+ RNA, total RNA 
was used in these Northern blot experiments. We then sepa- 
rated the RNA into non-polyA+ and polyA+ fractions, and 
again analyzed by Northern blots. A positive signal, seen just 
below the 28s ribosomal RNA band, was only detected in the 
total RNA and non-polyA+ fraction of total RNA from 
MSFA-1 cells (Fig. 2A, lanes 1,2). No positive signal was 
observed with RNA from MSFA-3 cells (Fig. 2A, lanes 4- 
6). The same blots were then probed with GAPDH to confirm 
the adenylation nature and the integrity of the separated 
RNA fractions (Fig. 2B). 
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4. Discussion 
The establishment of stable clonal cell lines from mouse 
3T3 cells suggested an in vitro model system to examine adi- 
pocyte differentiation. We had demonstrated earlier that 
transfection of genomic DNA from tissue presumably with 
active sequences is able to commit the null cell clone 3T3- 
C2 to undergo adipogenesis. Furthermore, we were able to 
show that the activities resided in two small nonhomologous 
sequences. In this communication we present evidence that the 
expression of one of the sequences is under temporal regula- 
tion. 
There are several models of developmental decision and 
determination. Examples of known mechanisms that would 
allow stable expression include inherited modifications of 
chromatin such as methylation, demethylation or the creation 
of a new gene by DNA rearrangement (as takes place in the 
immune system or in the antigen switching of certain trypa- 
nosomes). Another way to modulate expression of sets of 
genes would be by the formation of a stable transcription 
complex resulting from the combination of necessary factors 
within a particular cell. Recent studies, for example, suggest 
that different promoters may require different basal transcrip- 
tion factors [28]. Yet another mechanism recently observed to 
regulate cell growth and differentiation was shown to be 
mediated by a 3’-untranslated RNA (UTR). Using a genetic 
complementation assay based on function, 3’-UTRs of three 
muscle structural genes were found to act as trans-acting reg- 
ulators that inhibited cell proliferation and promoted differ- 
entiation [29932]. These or other unknown mechanisms may 
be used by the adipocyte differentiation pathway. 
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